This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
During a recent trip to China, I learned that Chinese physicians have been using local snake venom for medicinal purposes. In western China, a product derived from the venom of the Malayan pit viper has proven to be as potent a thrombolytic agent as a tissue plasminogen activator. I read in a popular magazine that the government of Suriname, a sparsely populated country in South America, is encouraging pharmaceutical eco-research in its vast tropical forests. In this country, shamans claim ancestral knowledge of the medicinal properties of hundreds of plants. Traditional medicines used for thousands of years are often ignored, if not scorned by scientific medicine. Should the next decade be devoted to the investigation of traditional medicines and pharmaceutical eco-research before the industrial development of these areas cause the resources to disappear?
NEUROLOGISTS IN FAR AWAY PLACES
Most people do not realize that Urumqi is the capital city of Xinjiang Uygur Autonomous Region, and yet Urumqi has a population of 1.5 million inhabitants. Xinjiang, a vast area of 1.6 million square kilometers in western China, is situated between three mountain ranges, east to west, that create two natural basins and shape the basic geography and climate of the country. The Tarim basin, located in the south of Xinjiang, is covered by the Taklimakan desert, the largest desert in China and the second largest in the world. FIGURE
Tan Yu Hui
Xinjiang is populated by 13 ethnic groups, of which the Uygur are dominant. Dr. Tan Yu Hui is the chief neurologist of the People’s Hospital of Urumqi, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg